의료용 로봇 시장 예측(-2034년) : 제품 유형, 구성부품, 기술, 제어 방식, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Medical Robotics Market is accounted for $16.8 billion in 2026 and is expected to reach $55.2 billion by 2034, growing at a CAGR of 16.1% during the forecast period. Medical Robotics encompasses a diverse range of robotic systems designed to augment or automate clinical tasks across surgical, rehabilitative, diagnostic, and hospital logistics domains. Surgical robots extend surgeon precision through tremor filtration and enhanced visualization, while rehabilitation robots support motor function recovery for neurological and orthopedic patients. Hospital and pharmacy robots automate medication dispensing, disinfection, and supply delivery, reducing manual workload and human error rates.

Market Dynamics:

Driver:

Growing adoption of minimally invasive surgical procedures globally

Patient and clinical preference for minimally invasive surgery continues to expand robotic surgery adoption across diverse specialties. Robotic platforms deliver superior dexterity in confined anatomical spaces, enabling complex procedures through smaller incisions that result in reduced postoperative pain, shorter hospital stays, and faster patient recovery. Health system administrators recognize the reputational and reimbursement advantages of offering robotic surgery programs, stimulating capital investment in surgical robotics. As procedure volumes grow and per-procedure costs decline through operational experience, the economic case for robotic surgery platforms strengthens, broadening adoption from tertiary centers to community hospitals in developed and emerging markets alike.

Restraint:

High capital investment and steep learning curves for surgical systems

The upfront acquisition cost of sophisticated surgical robotic systems remains a significant barrier for smaller hospitals and healthcare systems in lower-income countries. Beyond hardware investment, institutions must budget for consumable instruments, maintenance contracts, and extensive surgeon training programs, substantially increasing the total cost of ownership. The learning curve associated with robotic surgery proficiency requires significant case volumes before surgeons achieve optimal efficiency, creating opportunity costs during the ramp-up period. Regulatory approval processes for novel robotic devices are rigorous and time-consuming, extending time-to-revenue for new entrants and constraining the pace of market innovation.

Opportunity:

Emergence of next-generation autonomous and AI-guided robotic platforms

The integration of machine learning, computer vision, and autonomous control systems into medical robotics is ushering in a new generation of platforms capable of semi-autonomous procedure execution, real-time intraoperative guidance, and adaptive surgical planning. AI-guided robots can analyze pre-operative imaging to generate precise surgical maps and alert surgeons to critical anatomical structures in real time. In rehabilitation, AI-powered exoskeletons adapt exercise intensity based on continuous biomechanical feedback. These capabilities substantially expand the value proposition of robotic platforms beyond traditional manual task assistance, opening new clinical application areas and creating compelling differentiation for next-generation product launches.

Threat:

Device malfunctions and stringent post-market surveillance requirements

High-profile reports of robotic surgery complications attributable to technical malfunctions have intensified regulatory scrutiny of medical robotics post-market surveillance obligations. Regulatory agencies are mandating more comprehensive adverse event reporting, real-world evidence generation, and device performance tracking programs, increasing ongoing compliance costs for manufacturers. Product recalls, even when precautionary, generate significant reputational and financial consequences. The complex mechanical and software architectures of modern robotic systems create multiple potential failure points, requiring manufacturers to maintain extensive quality management systems and rapid field service capabilities to meet safety expectations.

Covid-19 Impact:

The COVID-19 pandemic created significant disruption for medical robotics through the suspension of elective surgeries, which sharply reduced procedure volumes and robot utilization for the majority of 2020. However, the crisis also validated the utility of robotic systems in minimizing clinical staff exposure to infectious patients during certain procedures. Post-pandemic surgical backlogs are driving elevated robotic procedure volumes as hospitals work to clear waiting lists. The experience also accelerated interest in autonomous hospital robots for disinfection and logistics, a segment that saw particularly strong growth following the pandemic and maintains elevated investment activity.

The Surgical Robots segment is expected to be the largest during the forecast period

The Surgical Robots segment is expected to account for the largest market share during the forecast period, driven by the majority of total market revenue driven by the high unit values of robotic surgical platforms and the substantial consumable instrument revenue generated per procedure. Laparoscopic and urological robotic systems have achieved significant penetration in developed market hospitals, with orthopedic robots representing the fastest-growing sub-category within this segment. The concentration of major robotics vendors' commercial efforts in surgical applications, combined with growing surgeon preference for robotic-assisted techniques across soft tissue and hard tissue specialties, solidifies surgical robots' dominant market position.

The Cloud Robotics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Cloud Robotics segment is predicted to witness the highest growth rate. Cloud-connected robotic platforms transmit operational data to centralized analytics engines, enabling remote performance monitoring, predictive maintenance, and continuous software optimization through over-the-air updates. This architecture dramatically reduces downtime by enabling proactive servicing before component failure. Cloud connectivity also facilitates telesurgery applications, where expert surgeons can guide procedures at remote sites. As hospital IT infrastructure matures and cybersecurity frameworks for medical devices strengthen, cloud robotics adoption is expected to accelerate across all robotic platform categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by the early market entry and widespread institutional adoption of robotic surgery systems from leading vendors. The United States accounts for the majority of global robotic surgical procedures, supported by favorable hospital capital budgets, robust private insurance reimbursement for robotic-assisted procedures, and a culture of technology adoption in academic and community hospital settings. A well-established regulatory pathway for medical devices, combined with a large population requiring chronic disease-related surgical intervention, ensures North America's continued market leadership through the forecast horizon.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by rapidly expanding healthcare infrastructure investment across China, Japan, India, and South Korea. China's government has identified medical robotics as a strategic national industry, supporting domestic manufacturers through subsidized R&D programs and hospital procurement incentives. Japan's aging population generates increasing demand for rehabilitation robots and surgical precision. The region's growing population of affluent urban patients willing to pay for minimally invasive surgical procedures, combined with healthcare system capacity expansion, creates strong structural growth dynamics.

Key players in the market

Some of the key players in Medical Robotics Market include Intuitive Surgical, Stryker, Medtronic, Zimmer Biomet, Johnson & Johnson, Smith & Nephew, CMR Surgical, Asensus Surgical, Accuray, Omnicell, Siemens Healthineers, GE HealthCare, Globus Medical, Renishaw plc, Brainlab AG.

Key Developments:

In April 2026, Zimmer Biomet Zimmer Biomet reported strong adoption metrics for its ROSA robotic surgery platform in total knee and total hip arthroplasty procedures, announcing expanded training center partnerships to accelerate surgeon certification programs and broaden institutional access to robotic orthopedic surgery capabilities across North American hospital networks.

In February 2026, Intuitive Surgical Intuitive Surgical announced the commercial launch of its da Vinci 5 robotic surgical system featuring enhanced force feedback capabilities and an expanded instrument portfolio, marking a significant product generational upgrade designed to improve surgical precision across soft tissue and reconstructive procedures in complex anatomical environments.

Product Types Covered:

• Surgical Robots
• Rehabilitation Robots
• Hospital & Pharmacy Robots
• Diagnostic Robots
• Radiotherapy Robots

Components Covered:

• Robotic Systems
• Instruments & Accessories
• Software
• Services

Technologies Covered:

• Artificial Intelligence (AI)
• Machine Learning
• Computer Vision
• Haptic Technology
• IoMT
• Cloud Robotics

Control Mechanisms Covered:

• Direct Telemanipulator Systems
• Computer-Controlled Systems
• Shared-Control Systems

Applications Covered:

• Surgery
• Rehabilitation Therapy
• Diagnostics
• Pharmacy Automation
• Hospital Logistics
• Telemedicine
• Elderly Care
• Radiation Therapy

End Users Covered:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Rehabilitation Centers
• Research Institutes
• Pharmacies

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Medical Robotics Market, By Product Type

• 5.1 Surgical Robots
  • 5.1.1 Laparoscopic Robots
  • 5.1.2 Orthopedic Robots
  • 5.1.3 Neurosurgical Robots
  • 5.1.4 Cardiology Robots
  • 5.1.5 Gynecology Robots
  • 5.1.6 Urology Robots
  • 5.1.7 General Surgery Robots
• 5.2 Rehabilitation Robots
• 5.3 Hospital & Pharmacy Robots
  • 5.3.1 Automated Dispensing Robots
  • 5.3.2 Disinfection & Sanitization Robots
  • 5.3.3 Delivery & Transportation Robots
  • 5.3.4 Telepresence Robots
• 5.4 Diagnostic Robots
• 5.5 Radiotherapy Robots

6 Global Medical Robotics Market, By Component

• 6.1 Robotic Systems
• 6.2 Instruments & Accessories
• 6.3 Software
• 6.4 Services

7 Global Medical Robotics Market, By Technology

• 7.1 Artificial Intelligence (AI)
• 7.2 Machine Learning
• 7.3 Computer Vision
• 7.4 Haptic Technology
• 7.5 Internet of Medical Things (IoMT)
• 7.6 Cloud Robotics

8 Global Medical Robotics Market, By Control Mechanism

• 8.1 Direct Telemanipulator Systems
• 8.2 Computer-Controlled Systems
• 8.3 Shared-Control Systems

9 Global Medical Robotics Market, By Application

• 9.1 Surgery
• 9.2 Rehabilitation Therapy
• 9.3 Diagnostics
• 9.4 Pharmacy Automation
• 9.5 Hospital Logistics
• 9.6 Telemedicine
• 9.7 Elderly Care
• 9.8 Radiation Therapy

10 Global Medical Robotics Market, By End User

• 10.1 Hospitals
• 10.2 Ambulatory Surgical Centers
• 10.3 Specialty Clinics
• 10.4 Rehabilitation Centers
• 10.5 Research Institutes
• 10.6 Pharmacies

11 Global Medical Robotics Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Intuitive Surgical
• 14.2 Stryker
• 14.3 Medtronic
• 14.4 Zimmer Biomet
• 14.5 Johnson & Johnson
• 14.6 Smith & Nephew
• 14.7 CMR Surgical
• 14.8 Asensus Surgical
• 14.9 Accuray
• 14.10 Omnicell
• 14.11 Siemens Healthineers
• 14.12 GE HealthCare
• 14.13 Globus Medical
• 14.14 Renishaw plc
• 14.15 Brainlab AG